Medline ® Abstract for Reference 54
of 'Interferon-gamma release assays for diagnosis of latent tuberculosis infection'
54
TI
Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
AU
Banaei N, Gaur RL, Pai M
SO
J Clin Microbiol. 2016;54(4):845. Epub 2016 Jan 13.
Interferon gamma release assays (IGRAs) are blood-based tests intended for diagnosis of latent tuberculosis infection (LTBI). IGRAs offer logistical advantages and are supposed to offer improved specificity over the tuberculin skin test (TST). However, recent serial testing studies of low-risk individuals have revealed higher false conversion rates with IGRAs than with TST. Reproducibility studies have identified various sources of variability that contribute to nonreproducible results. Sources of variability can be broadly classified as preanalytical, analytical, postanalytical, manufacturing, and immunological. In this minireview, we summarize known sources of variability and their impact on IGRA results. We also provide recommendations on how to minimize sources of IGRA variability.
AD
Department of Pathology, Stanford University School of Medicine, Stanford, California, USA Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA Clinical Microbiology Laboratory, Stanford Health Care, Stanford, California, USA nbanaei@stanford.edu.
PMID